Hikma Pharmaceuticals Plc Director/PDMR Shareholding (4403C)
13 April 2017 - 5:58PM
UK Regulatory
TIDMHIK
RNS Number : 4403C
Hikma Pharmaceuticals Plc
13 April 2017
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
1 Details of the person discharging managerial
responsibilities / person closely associated
--------------------------------------------------------------
a) Name Michael Raya
-------------------- ----------------------------------------
2 Reason for the notification
--------------------------------------------------------------
a) Position/status CEO of West-Ward Pharmaceuticals
-------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
-------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
-------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
-------------------- ----------------------------------------
b) Nature of Further Shares disposed from vesting
the transaction of the conditional awards on 10 April
2017 under the 2014 Executive Incentive
Plan (EIP). An additional 2,370 shares
were sold to cover tax and associated
costs resulting in 9,383 shares being
retained.
-------------------- ----------------------------------------
c) Price(s) and Price Volume(s)
volume(s) ---------- ----------
GBP19.42 2,370
---------- ----------
GBP0.00 9,383
---------- ----------
-------------------- ----------------------------------------
d) Aggregated GBP19.42
information GBP46,025
-------------------- ----------------------------------------
e) Date of the 12 April 2017
transaction
-------------------- ----------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
-------------------- ----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGRGDSLUBBGRX
(END) Dow Jones Newswires
April 13, 2017 03:58 ET (07:58 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024